Canopy Partners, LLC Dr Reddys Laboratories LTD Transaction History
Canopy Partners, LLC
- $215 Billion
- Q2 2024
A detailed history of Canopy Partners, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Canopy Partners, LLC holds 3,670 shares of RDY stock, worth $271,543. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,670
Previous 3,317
10.64%
Holding current value
$271,543
Previous $243 Million
14.93%
% of portfolio
0.13%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
232Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$153 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$152 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$150 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$148 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$133 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...